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Objective: Little is known about the
neurobiology of bipolar II disorder. While
bipolar I disorder is associated with abnor-
mally elevated activity in response to
reward in the ventral striatum, a key
component of reward circuitry, no studies
have compared reward circuitry function
in bipolar I and bipolar II disorders.
Furthermore, associations among reward
circuitry activity, reward sensitivity, and
striatal volume remain underexplored in
bipolar and healthy individuals. The
authors examined reward activity in the
ventral striatum in participants with bi-
polar I and II disorders and healthy
individuals, the relationships between
ventral striatal activity and reward sensi-
tivity across all participants, and between-
group differences in striatal gray matter
volume and relationships with ventral
striatal activity across all participants.
Method: Twenty healthy comparison sub-
jects and 32 euthymic bipolar I (N=17) and
bipolar II (N=15) patients underwent a neu-
roimaging reward paradigm during func-
tional MRI scanning, structural scanning,
and completed psychometric and clinical
assessments.
Results: Region-of-interest analyses re-
vealed signiﬁcant ventral striatal activity
in all participants during reward anticipa-
tion that was signiﬁcantly greater in bi-
polar II patients compared with the other
groups. Ventral striatal activity during re-
ward anticipation correlated positively
with reward sensitivity and fun seeking
across all participants. Bipolar II patients
had signiﬁcantly greater left putamen
volume than bipolar I patients, and left
putamen volume correlated positively
with left ventral striatal activity to reward
anticipation in all participants.
Conclusions: Abnormally elevated ven-
tral striatal activity during reward antici-
pation may be a potential biomarker of
bipolar II disorder. These ﬁndings highlight
the importance of adopting a dimensional
approach in the study of neural mecha-
nisms supporting key pathophysiological
processes that may cut across psychiatric
disorders.
Am J Psychiatry Caseras et al.; AiA:1–9
Early reports have suggested that bipolar disorder type
II was more benign than type I because individuals with
bipolar II disorder never experience full-blown mania. It
is now clear, however, that bipolar II disorder includes
multiple protracted depressive episodes (1) and is at least
as disabling as bipolar I disorder (2), with a lifetime
prevalence ranging from 1.1% to 11% (1, 3). Still, very little
is known about the neurobiology of the illness.
Studies have indicated that individuals with bipolar I
or bipolar II disorder may be characterized by reward
hypersensitivity, and this may underlie a higher presence
of approach behaviors and a predisposition to hypomania
or mania, emotional lability, and mood dysregulation (4).
For example, studies with bipolar individuals have re-
ported higher self-reported scores on measures of reward
sensitivity (5, 6), an association between heightened re-
ward sensitivity and a more severe illness course (7),
deﬁcits in learning paradigms requiring stopping or
delaying responses to rewarding stimuli (8), and a ten-
dency for rewarding life events to precipitate hypomanic
or manic episodes (9, 10).
The ventral striatum is a core component of the neural
circuitry underlying reward processing (11, 12) and is part
of a larger corticolimbic reward circuit that includes the
ventral prefrontal cortex (12, 13). Studies with bipolar I
patients have reported elevated ventral striatal activity
to socially rewarding stimuli (happy faces) in remitted
individuals (14), elevated ventrolateral prefrontal cortical
activity during reward anticipation during mania (15), and
elevated ventral striatal and ventrolateral prefrontal
cortical activity to reward anticipation during euthymia
(16).
Together, these ﬁndings support a reward hypersensi-
tivity model of bipolar disorder, although no studies to our
knowledge have compared reward circuitry between bi-
polar types. Given the dimensional focus of the Research
Domain Criteria (17), bipolar I and bipolar II disorder may
be conceptualized as a spectrum of disorders in which
reward hypersensitivity is a key dimension of pathology,
but this remains unexamined. Furthermore, no studies to
our knowledge have compared reward circuitry gray
matter volume in individuals with bipolar I and bipolar II
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disorder, although some studies have reported greater
ventral striatal volume in bipolar relative to healthy
adolescents (18, 19).
Our aims in this study were to examine 1) activity and
gray matter volume in reward-related neural circuitry in
patients with bipolar I disorder, bipolar II disorder, and
healthy comparison subjects and 2) the extent to which
reward-circuitry activity during reward processing was
associated with reward sensitivity across all participants.
Given the key role of the ventral striatum in reward
processing (11, 12), along with previous ﬁndings (16), our
speciﬁc focus was the examination of ventral striatal
activity, although we also wished to examine whole-brain
response to reward. We focused on examining euthymic
bipolar I and bipolar II patients to identify neuroimaging
measures that were independent of mood state-related
inﬂuences and in turn could potentially more accurately
diagnose bipolar II disorder in patients across different
mood states in the future. Previous ﬁndings allowed us to
hypothesize the following:
1. Bipolar patients would produce greater ventral striatal
activity during reward processing than healthy comparison
subjects. We also wished to determine whether ventral
striatal activity during reward processing would differ
between bipolar I and bipolar II patients.
2. Across all study participants, the magnitude of
reward sensitivity and ventral striatal activity to reward
processing would be positively correlated.
3. Bipolar patients would have greater striatal volume
than healthy comparison subjects. We also wished to
explore the relationship between striatal volume and
activity during reward processing across all participants.
Method
Participants and Questionnaires
Euthymic bipolar I and bipolar II patients were recruited
from a preexisting database of well-characterized patients
participating in ongoing molecular genetic studies at Cardiff
University and through local community mental health teams.
Comparison subjects were recruited from the community using
advertisements.
A qualiﬁed clinical psychologist (X.C.) administered the Mini-
International Neuropsychiatric Interview (20) to conﬁrm di-
agnosis and exclude participants with a recent history (,1 year)
of substance abuse or dependence or borderline personality
disorder. To quantify the potential presence of residual symp-
toms of depression and hypomania or mania, the Hamilton
Depression Rating Scale (HAM-D) (21) and the Young Mania
Rating Scale (22) were also administered. Euthymia was deﬁned
as the absence of episodes of depression, mania, or hypomania
for 2 months before scanning, based on clinical interview, plus
scores ,10 on the HAM-D and the Young Mania Rating Scale.
Healthy comparison subjects were also interviewed using the
Mini-International Neuropsychiatric Interview, the HAM-D, and
the Young Mania Rating Scale. Healthy participants were ex-
cluded for the same criteria as patients as well as for any personal
or family history of affective or psychotic disorders or current
psychiatric disorder.
All participants completed a questionnaire (the BIS/BAS scales)
assessing the strength of the behavioral inhibition and behavioral
activation systems (23), which regulate aversive motives and in-
hibition of action in response to negative stimulation (inhibition
system), and appetitive motives and preparation to move toward
desirable stimuli (activation system). The behavioral activation
system is divided into three scales—drive, fun seeking, and reward
responsiveness—that account for different aspects of incentive
sensitivity. Patients also completed the Hypomanic Checklist–32
(24), a screening tool for bipolar disorder that allows for a de-
tailed description of hypomanic and manic episodes. Verbal IQ
was assessed in all participants using the National Adult Reading
Test (25).
Two bipolar I patients were excluded because of concerns that
they were no longer euthymic on the day of the scan. The ﬁnal
sample included 20 healthy comparison subjects and 32 bipolar
patients (17 with bipolar I disorder and 15 with bipolar II
disorder). One healthy comparison subject and one bipolar I
patient were excluded from the reward paradigm analyses
because they had more than three missing trials, suggesting
poor engagement or understanding of the task.
All participants gave written informed consent and were paid
£20 for participating. The study was approved by the local
National Health System research ethics committee.
Experimental Procedure
We employed a monetary reward-processing task that has
been shown to activate the ventral striatum (16, 26). The task was
back-projected so that participants could see it through a mirror
mounted on the head coil. Participants guessed the numeric
value of cards in order to win or avoid losing money. Each trial
included an anticipation phase, during which participants waited
for the outcome of their guess, followed by the actual outcome
(see the supplementary material in the data supplement that ac-
companies the online edition of this article). Participants practiced
the task before scanning.
Image Acquisition and Data Analysis
Participants performed the task during an optimized func-
tional MRI (fMRI) data acquisition protocol. An anatomical brain
scan was also obtained using a 3-T General Electric HDx MRI
scanner. fMRI data processing was performed using FMRIB’s
Software Library (www.fmrib.ox.ac.uk/fsl), and preprocessing the
functional data followed standard methods (see the online data
supplement). The task was modeled within the general linear
modeling framework, with crosshair periods as baseline stimuli.
The anticipation periods were divided into independent events
representing the initial 2 seconds and the remaining anticipation
time. Since we assumed the effect of reward anticipation to be
more prominent at the beginning of the anticipation, because of
potential habituation effects, all the analyses reported here refer
to the initial 2 seconds of the anticipation phase.
An a posteriori analysis with time as the within-subject factor
(the initial 2 seconds compared with the rest of the anticipation
period) and group as the between-subjects factor revealed a
signiﬁcant time-by-group interaction on activity in the ventral
striatum (F=4.54, df=2, 47, p,0.05), reﬂecting a reduction in the
group differences as the anticipation period progressed. This
result supported our a priori strategy of focusing our analyses on
the initial 2 seconds of the anticipation period. We were also
interested in all positive outcomes; therefore, our outcome var-
iable included trials in which participants won after anticipating
reward and trials in which participants avoided losing after
anticipating punishment. Thus, our contrasts of interest were
anticipation of reward relative to intertrial crosshair baseline and
positive outcome relative to intertrial crosshair baseline. The full
model also included events for anticipation of punishment and
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negative outcomes. The resulting functional images were con-
verted to the standard space of the Montreal Neurological In-
stitute (MNI) using FMRIB’s linear registration tool (FLIRT).
Higher-level analysis was carried out using FMRIB’s local analysis
of mixed effects (FLAME) (27).
Since our hypotheses were strongly focused on the ventral
striatum, region-of-interest analyses were conducted within
a mask of two 8-mm radius spheres (Figure 1) based on MNI
coordinates (right: x=9, y=9, z=28; left: x=29, y=9, z=28) from
previous meta-analyses (28, 29). 3dClustSim within AFNI was
used on the normalized images (voxel size, 2 mm isotropic) to
determine that a corrected p,0.05 within this region of interest
required a voxel-wise threshold of p,0.05 coupled with a cluster
size criterion of 41 voxels. Subsequently, we conducted explor-
atory whole-brain analyses using a voxel-wise Z statistic .2 and
a cluster-corrected threshold of p,0.05. In both region-of-
interest and whole-brain analyses, we conducted a voxel-wise
analysis of variance (ANOVA) to examine the main group factor,
and we performed post hoc pairwise between-group compar-
isons as appropriate. Although not directly related to the
objectives of this study, results of the three (group) by two
(condition: reward anticipation relative to punishment anticipation)
ANOVA and the analysis of the effect of group on punishment
anticipation are presented in the online data supplement.
To test our second hypothesis, we examined relationships
between ventral striatal activity (highest peak percentage blood-
oxygen-level-dependent [BOLD] signal change within our pre-
deﬁned region of interest) during reward anticipation and
outcome and behavioral activation system scores using correla-
tion analyses. The relationships between ventral striatal activity
and residual manic or depressive symptoms (HAM-D, Young
Mania Rating Scale, and Hypomanic Checklist–32 scores) were
also investigated. To avoid ﬂoor effects produced by the high fre-
quency of zero scores on clinical measures in healthy comparison
subjects, correlation analyses with these scales were performed
only for bipolar patients. Given the nonnormal distribution of
ventral striatal activity, nonparametric Spearman’s rho analyses
were conducted.
Structural MRI data were processed with the fully automated
segmentation procedure in Freesurfer (http://surfer.nmr.mgh.
harvard.edu/; see the online data supplement). We focused on
examining ventral striatal volume, including the putamen and
nucleus accumbens, which have been shown to be contiguous
ventral striatal regions in humans (30). Following subcortical
FIGURE 1. Neural Activity Associated With Anticipation of Potential Rewarda
a These images are presented in radiological convention, with the left side of the image representing the right hemisphere and vice versa. The
top row (A) shows the anatomical masks used in the regionally restricted analysis accounting for group differences in ventral striatal activity
(in white), and the clusters of activity found to be increased in bipolar II patients relative to healthy comparison subjects (blue) and bipolar I
patients (red). No other signiﬁcant differences were observed. For display purposes, an estimation of the percentage of blood-oxygen-level-
dependent (BOLD) signal change within the ventral striatum per group is presented on the right. Raw BOLD signal change in the voxels that
showed signiﬁcant activity during the initial 2 seconds of anticipation of reward for all participants (after regressing out the remainder of the
anticipation period) was extracted using the Featquery tool in FMRIB’s Software Library. The ﬁrst value of the time series was considered the
baseline in order to calculate the percentage of BOLD signal change. The bottom row (B) shows the BOLD responses obtained from the whole-
brain analysis when pooling all of the participants together (left) and the clusters showing signiﬁcantly greater activity in bipolar II patients
relative to healthy comparison subjects (blue) and bipolar I patients (red). No other signiﬁcant differences were observed.
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segmentation, we compared the volumes of these regions be-
tween groups using ANOVA and pairwise comparisons, and we
performed correlation analyses to examine relationships with
peak ventral striatal activity (as for the above correlation).
Demographic and clinical characteristics were compared
across groups using ANOVA followed by pairwise comparisons
or chi-square tests as appropriate.
Results
Behavioral Responses and Demographic
Characteristics
Post hoc analysis of the reaction time to the guessing
cues that preceded the reward anticipation periods re-
vealed no differences between groups, suggesting similar
levels of engagement.
Table 1 summarizes participants’ demographic and
clinical characteristics. Groups were matched for gender,
age, and estimated verbal IQ (p.0.1 in all cases). Healthy
comparison subjects had lower scores than both bipolar
patient groups on residual mood symptoms measured by
the HAM-D (F=6.18, df=2, 49, p,0.005) and the Young
Mania Rating Scale (F=29.37, df=2, 49, p,0.005); the two
bipolar groups had similar scores, although bipolar I
patients tended to have higher Young Mania Rating Scale
scores (p=0.07). The bipolar patient groups did not differ
on the number of manic symptoms experienced during
“highs” (Hypomanic Checklist–32), age at ﬁrst mood epi-
sode, age at ﬁrst bipolar diagnosis, or time from ﬁrst mood
episode until diagnosis. Slightly under half of the bipolar
patients had identiﬁed a family history of bipolarity in
ﬁrst-degree relatives, the distribution of which did not
differ between bipolar I and bipolar II disorder. However,
among those not reporting a family history of bipolarity,
64% reported the presence of depression in at least one
ﬁrst-degree relative. No group differences were observed
on any of the behavioral activation system scales, but both
bipolar patient groups had greater behavioral inhibition
system scores than healthy comparison subjects (F=11.61,
df=2, 47, p,0.001) (data from two participants were
missing for the BIS/BAS questionnaire).
Most bipolar patients were taking psychotropic medi-
cation; only one bipolar I patient and ﬁve bipolar II pa-
tients had beenmedication free for more than 2months at
TABLE 1. Demographic and Clinical Characteristics for Healthy Comparison Subjects, Bipolar I Patients, and Bipolar II
Patients in a Study of Ventral Striatum Activity
Characteristica
Healthy Comparison Subjects
(N=20)
Bipolar I Patients
(N=17)
Bipolar II Patients
(N=15)
Mean SD Mean SD Mean SD
Age (years) 42.30 5.99 42.82 7.31 40.53 8.09
IQ 115.73 7.73 114.52 8.02 113.10 6.91
Hamilton Depression Rating Scale score 0.60b 0.94 3.88 3.87 2.67 2.94
Young Mania Rating Scale score 0.65b 0.93 3.17 2.32 1.80 2.80
Hypomania Checklist–32 score 23.73 5.99 23.13 4.82
Age at ﬁrst mood episode (years) 17.57 5.41 18.92 7.63
Age at bipolar diagnosis (years) 27.06 6.43 31.00 10.05
Time from ﬁrst mood episode to
diagnosis (years)
10.76 8.83 12.33 9.98
BIS scale score 16.61b 4.95 22.50 2.70 22.43 4.12
BAS-RR scale score 15.00 2.56 16.44 2.58 16.00 2.60
BAS-FS scale score 10.06 2.94 11.69 2.08 11.21 2.81
BAS-D scale score 9.00 2.81 10.62 2.75 10.57 2.65
N % N % N %
Family history of bipolar disorderc 7 46 5 36
Female 13 65 11 64 9 60
Taking mood stabilizersd 12 75 10 67
Taking antipsychoticse 9 56 3 20
Taking antidepressantsf 6 37 6 40
Comorbid anxiety 5 29 4 27
a BIS=behavioral inhibition system; BAS=behavioral activation system; RR=reward responsiveness; FS=fun seeking; D=drive.
b Signiﬁcant differences between comparison subjects and patient groups (p,0.05). Bipolar I and bipolar II patients did not differ signiﬁcantly
on any measure.
c Family history of bipolar disorder up to second-degree relatives. This information was missing from two bipolar I patients and one bipolar II
patient.
d There is no dose equivalence available in the literature for mood stabilizers; however, almost all bipolar I and bipolar II patients taking mood
stabilizers in our sample were taking lithium, 800 mg/day, or sodium valproate, 1,000 mg/day, with no signiﬁcant differences in dosage of
these medications between the two patient groups.
e Bipolar I patients were taking a mean chlorpromazine-equivalent dosage of 428 mg/day, and bipolar II patients were taking a mean
chlorpromazine-equivalent dosage of 259 mg/day.
f Bipolar I patients were taking a mean imipramine-equivalent dosage of 164 mg/day, and bipolar II patients were taking a chlorpromazine-
equivalent dosage of 151 mg/day.
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the time of scanning. Bipolar I patients tended to be
taking more antipsychotic medications than bipolar II
patients, but the difference fell short of signiﬁcance
(x2=4.29, p=0.07). The proportion of bipolar I and bipolar
II patients with DSM-IV comorbid anxiety diagnoses did
not differ.
Ventral Striatal Activity
Region-of-interest analysis for reward anticipation
revealed signiﬁcant ventral striatal activity for the entire
sample. Amain effect of group was observed (F=3.61, df=2,
47, p,0.05), with greater bilateral ventral striatal activity in
bipolar II patients than in healthy comparison subjects
(p,0.05, 169 voxels) and bipolar I patients (p,0.05, 131
voxels). No differences were observed between bipolar I
patients and healthy comparison subjects (Figure 1).
Region-of-interest analysis for positive outcome re-
vealed a cluster of activity that approached but did not
meet signiﬁcance in the entire sample (p,0.05, 25 voxels).
However, a main effect of group was observed (F=3.35,
df=2, 47, p,0.05), with greater right ventral striatal activity
in bipolar I patients than in bipolar II patients (p,0.05,
51 voxels). Bipolar I patients also exhibited signiﬁcantly
greater left ventral striatal activity than healthy compar-
ison subjects, but this difference did not survive cluster-
wise correction (p,0.05, 15 voxels).
Whole-Brain Analysis
For the entire sample, signiﬁcant activity during reward
anticipation was observed in the left superior temporal
cortex, insula, putamen and claustrum, ventrolateral pre-
frontal cortex, and precentral gyrus (Figure 1). No sig-
niﬁcant overall group effect was observed in these regions.
Planned pairwise comparisons did, however, reveal sig-
niﬁcantly greater activity in bipolar II patients relative to
healthy comparison subjects and bipolar I patients in the
left ventrolateral prefrontal cortex, insula, precentral gy-
rus, and middle and superior temporal cortex. Bipolar II
patients also exhibited greater activity than healthy com-
parison subjects in the caudate nuclei bilaterally and the
left dorsolateral prefrontal cortex (Figure 1 and Table 2).
No signiﬁcant differences were observed between bipolar I
patients and healthy comparison subjects.
Whole-brain analysis of activity to positive outcome did
not yield any signiﬁcant cluster of activity or differences
between groups.
Ventral Striatal Activity, Reward Sensitivity, and
Clinical Measures
Supporting our second a priori hypothesis, left and right
ventral striatal activity during reward anticipation was
positively correlated with scores on the behavioral activa-
tion system fun-seeking scale across all individuals (r
s
=0.312,
p,0.05; r
s
=0.385, p,0.01, respectively) (Figure 2). No
signiﬁcant correlations were observed between ventral
striatal activity and scores on the HAM-D, the YoungMania
Rating Scale, and the Hypomanic Checklist–32 scores.
No signiﬁcant relationships were observed between
ventral striatal activity to positive outcome and any behav-
ioral or clinical scores.
Striatal Gray Matter Volumes
Examination of striatal brain volumes indicated sig-
niﬁcant differences in the left putamen volume between
groups (F=3.24, df=2, 48, p,0.05), with bipolar II pa-
tients showing enlargement relative to bipolar I patients
(mean=5,834 mm3 [SD=648] and mean=5,278 mm3
[SD=701], respectively; p,0.05), as well as relative to
healthy comparison subjects, although the latter dif-
ference fell short of signiﬁcance (mean=5,420 mm3
[SD=512]; p=0.064). These analyses survived after con-
trolling for intracranial volume. No differences were
observed in the right putamen or accumbens volumes.
Across the whole sample, left putamen volume was posi-
tively correlated with left ventral striatal activity during
reward anticipation (r
s
=0.33, p,0.05) (Figure 2).
Antipsychotic Medication
As there was a trend towardmore bipolar I than bipolar II
patients taking antipsychotics, we repeated the above
TABLE 2. Local Maxima During Reward Anticipation
Obtained in the Whole Brain Between Healthy Comparison
Subjects, Bipolar I Patients, and Bipolar II Patients
Coordinates
Comparison and
Location
Brodmann’s
Area x y z Z
Bipolar I . healthy
comparison
None
Healthy comparison
. bipolar I
None
Bipolar II . healthy
comparison
Superior temporal
lobe
41 252 220 8 3.54
Dorsolateral
prefrontal
cortex
13 244 28 4 3.38
Posterior insula 13 244 214 12 3.36
Anterior insula 13 232 24 8 3.18
Ventrolateral
prefrontal cortex
47 244 34 24 3.11
Healthy comparison
. bipolar II
None
Bipolar I . bipolar II
None
Bipolar II . bipolar I
Ventrolateral
prefrontal cortex
47 230 28 220 3.24
Posterior insula 13 244 214 12 3.20
Middle temporal
lobe
21 236 212 210 3.16
Orbitofrontal cortex 11 230 38 216 3.08
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comparisons after excluding those patients taking this class
of medication (bipolar I patients, N=8; bipolar II patients,
N=12). Again, bipolar II patients had greater ventral striatal
activity during reward anticipation than bipolar I patients
(p,0.05, 53 voxels) and healthy comparison subjects
(p,0.05, 185 voxels). The bipolar I . bipolar II difference
in ventral striatal activity during positive outcome no longer
reached signiﬁcance. Similarly, the differences in whole-
brain activity between bipolar groups during reward anti-
cipation were not signiﬁcant here, although bipolar II
patients still showed greater activity than healthy compar-
ison subjects in the left ventrolateral prefrontal cortex,
insula, caudate, putamen, superior temporal cortex, and
precentral gyrus.
Following the approach used in other studies (17, 31,
32), we converted antipsychotic medication into chlor-
promazine equivalents (coded 0 for those not taking
antipsychotics) and used this index as a covariate.
Region-of-interest analyses revealed signiﬁcantly greater
ventral striatal activity in bipolar II patients during
reward anticipation than in healthy comparison subjects
(p,0.05, 172 voxels) and bipolar I patients (p,0.05,
60 voxels). During positive outcome, the bipolar I .
bipolar II difference in ventral striatal activity did not
reach signiﬁcance (p,0.05, 33 voxels). As before, whole-
brain analysis failed to replicate signiﬁcant differences
between bipolar I and bipolar II patients, but still
revealed signiﬁcantly greater activity in the left superior
temporal cortex, left insula, left caudate, and left ventrolat-
eral prefrontal cortex in bipolar II patients relative to
healthy comparison subjects.
Covarying for antipsychotic medication, a nonsigniﬁ-
cant main effect of group on left putamen volume was still
observed (F=2.57, df=2, 48, p=0.08).
FIGURE 2. Positive Correlations Between Peak Activity in the Ventral Striatum and Behavioral Scoresa
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a These scatterplots depict the highest percentage blood-oxygen-level-dependent (BOLD) signal change from baseline during reward
anticipation with the score in the behavioral activation system fun-seeking scale for the whole sample (healthy comparison subjects and
bipolar I and II patients) and the gray matter volume in the left putamen.
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Discussion
Our main goal in this study was to compare ventral
striatal activity during reward processing in euthymic
bipolar I and bipolar II patients and healthy comparison
subjects. While all participants exhibited ventral striatal
activity during reward anticipation, bipolar II patients
showed signiﬁcantly greater activity than either bipolar I
patients or healthy comparison subjects. During positive
outcome, however, bipolar I patients showed signiﬁcantly
greater ventral striatal activity than bipolar II patients, but
not healthy comparison subjects, although unlike reward
anticipation, this difference became nonsigniﬁcant after
controlling for potential effects of antipsychotic medica-
tion. Also supporting our hypotheses, the magnitude of
ventral striatal activity during reward anticipation was
positively correlated with the fun-seeking scale across all
participants. Furthermore, bipolar II patients had en-
larged left putamen volume relative to bipolar I patients,
and a positive correlation was observed between left
putamen volume and left ventral striatal activity during
reward anticipation across the whole sample.
The importance of our ﬁndings is twofold. First, we
demonstrate that bipolar II patients display elevated ven-
tral striatal activity to reward anticipation not only relative
to healthy comparison subjects but also relative to bipolar
I patients. This difference between bipolar groups was not
explained by differences in the severity of residual mood
symptoms or antipsychotic medication load. Second, the
pattern of ventral striatal activity observed across all
participants during reward anticipation was positively
associated with the fun/thrill-seeking component of the
behavioral activation system (33). This latter ﬁnding con-
curs with previous research linking ventral striatal activity
with the behavioral activation system (34) and with the
dimensional approach to the study of psychiatric disorders
advocated by the Research Domain Criteria (17), which
focuses on dimensions of behavior and related neural
circuitry function that cut across psychiatric diagnostic
categories. Our ﬁnding that ventral striatal activity in
response to positive outcome did not correlate with any of
the behavioral activation system scales is in agreement
with Gray’s model (35), in which this neurobiological
system engages in preparation to obtain, but not to re-
ceive, reward.
While the two bipolar patient groups and healthy
comparison subjects did not differ on self-reported mea-
sures of reward sensitivity, bipolar II patients exhibited
signiﬁcantly greater ventral striatal activity during reward
anticipation than in other groups. These ﬁndings suggest
either greater sensitivity of reward neural circuitry activity
than self-report measures in differentiating bipolar I and
II patients or greater ventral striatal activity for a given
level of self-reported fun and thrill seeking during reward
anticipation in bipolar II patients than other groups. Either
way, elevated ventral striatal activity during reward
anticipation may be a potential neural mechanism for
greater reward-seeking behavior and mood dysregulation
in bipolar II patients. To better understand inconsistencies
between ﬁndings for self-reported reward sensitivity and
ventral striatal activity, future research should include
other behavioral measures of reward sensitivity that may
be more sensitive to group differences.
Our ﬁndings of signiﬁcantly greater left putamen
volume in bipolar II relative to bipolar I patients as well
as a positive correlation between left putamen volume and
left ventral striatal activity during reward anticipation
suggest a structural neural basis for the between-group
differences in ventral striatal activity. This ﬁnding will
require further conﬁrmation given the decrease in statis-
tical signiﬁcance after controlling for antipsychotic med-
ication load. However, to our knowledge, these results
represent the ﬁrst demonstration of a potential structure-
function relationship in reward circuitry in bipolar disorder.
Interestingly, bipolar I patients displayed signiﬁcantly
greater ventral striatal activity than bipolar II patients
during positive outcome, suggesting that the former may
have beenmore sensitive to reward receipt than the latter,
although this difference did not remain after controlling
for the potential effects of antipsychotics. Furthermore,
the difference in ventral striatal activity during positive
outcome between bipolar I patients and healthy compar-
ison subjects did not meet the cluster-wise signiﬁcance
threshold. Together with the above ﬁndings, these may
suggest different neural mechanisms for vulnerability to
hypomanic or manic episodes in individuals with bipolar I
and II disorder—that is, heightened sensitivity to reward
anticipation in bipolar II disorder but to reward receipt in
bipolar I disorder. Further research would help to clarify
this point.
We observed some discrepancies between our results
and a previous report (16) showing signiﬁcantly greater
ventral striatal activity during reward anticipation in
euthymic bipolar I patients relative to healthy comparison
subjects. Unlike the previous study, participants in our
study were not led to believe that their remuneration was
dependent on task performance. Instead, we asked partic-
ipants to perform at their best and told them that per-
formance would be compared across participants. Earlier
studies have reported that social competition activates the
ventral striatum (36). Our ﬁndings may suggest that the
addition of this social reward component may be less
effective at activating the ventral striatum than monetary
reward during reward anticipation in bipolar I patients.
Exploratory whole-brain analyses revealed left fronto-
temporal and insula cortical activity during reward
anticipation. These neural regions are associated with
reward processing, in particular the ventrolateral pre-
frontal cortex (12). Between-group comparisons paralleled
the pattern of differences in ventral striatal activity: bipolar
II patients exhibited greater activity than other groups.
While these patterns of between-group differences further
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support greater sensitivity to reward anticipation in
bipolar II than in bipolar I patients or healthy comparison
subjects, these results were less robust than the ventral
striatal ﬁndings. It would therefore be useful to replicate
these ﬁndings and further clarify to what extent the
difference between bipolar patient groups may be related
to antipsychotic medication.
Some limitations are noted. The majority of patients
with bipolar disorder were receiving psychotropic medi-
cations. The potentially confounding effects of psychotro-
pic medication in bipolar neuroimaging research have
been discussed previously (37). Nevertheless, we were able
to replicate our ﬁndings regarding the differences in
ventral striatal activity after controlling for antipsychotic
load (in chlorpromazine equivalents) and after excluding
patients who were taking this medication class. Our ﬁnd-
ings in the ventral striatum for reward anticipation ap-
peared to be robust enough to survive these additional
analyses, but further replication is warranted, especially
because the duration of medication treatment was not
recorded during this study. No signiﬁcant group differ-
ences in self-reported measures of reward sensitivity were
observed, and our task does not produce a sensitive
behavioral output to detect between-group differences in
reward sensitivity. Future studies should include other
behavioral self-reported measures of reward sensitivity.
In summary, we report signiﬁcantly elevated ventral
striatal activity in bipolar II patients compared with
bipolar I patients and healthy comparison subjects, spe-
ciﬁcally during reward anticipation, and a signiﬁcant
positive correlation between ventral striatal activity to
reward anticipation and fun/thrill seeking. These ﬁndings
suggest that abnormally elevated ventral striatal activity
during reward anticipationmay be a biomarker of bipolar
II disorder, as previously shown for bipolar I disorder,
that could ultimately be used to help discriminate bipolar
from unipolar depressed patients. Moreover, bipolar I
and bipolar II patients may be distinguished by func-
tional differences in ventral striatal activity during reward
anticipation and outcome, which in turn may suggest
different neural mechanisms predisposing to mood dysre-
gulation across bipolar I and II disorders. Our ﬁndings are
among the ﬁrst to identify patterns of abnormal neural
activity in bipolar II disorder that may be potential targets
for therapeutic interventions for this disabling psychiatric
disorder.
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